A large co‐operative biological and clinical study to better understand and improve treatment of the rare t(8;16)(p11;p13) acute myeloid leukaemia Redazione 11 Febbraio 2021 ...
Prognostic models for chronic lymphocytic leukemia (CLL): a systematic review and meta-analysis Redazione 11 Febbraio 2021 ...
Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors Redazione 11 Febbraio 2021 ...
Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL Redazione 4 Febbraio 2021 ...
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis Redazione 4 Febbraio 2021 ...
Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID‐19 while we are awaiting the results of clinical trials? Redazione 4 Febbraio 2021 ...
Long‐term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab Redazione 4 Febbraio 2021 ...
Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Redazione 4 Febbraio 2021 ...